What this record means
The record shows that the mark IDACIO is live and registered on the Principal Register, owned by Fresenius Kabi Deutschland GmbH, a German limited‑liability company. It covers “pharmaceutical preparations for the treatment of autoimmune diseases, illnesses, and conditions” in International Class 005, with a first use date of July 1 2023, so a similar name used for any pharmaceutical product in that therapeutic area would present the closest record‑based concern. The record does not give the owner control over every possible use of the word IDACIO outside those listed goods, and it does not extend to unrelated products or services. The most recent meaningful event is the registration confirmation on November 28 2023, which also serves as the current status date; no future deadline appears in the data. The prosecution history contains no oppositions, cancellations or other enforcement actions, so the supplied history shows none. I'd treat this as a meaningful concern if you plan a pharmaceutical brand in the same therapeutic space.
Informational only - not legal advice.